Abiopharma

New Form SCHEDULE 13G/A - HARVARD BIOSCIENCE INC Filed: 2025-05-15 AccNo: 0001641172-25-010912 Size: 8 KB

New Form 5 - IGC Pharma, Inc. Filed: 2025-05-15 AccNo: 0001185185-25-000494 Size: 14 KB

New Form 4 - Organon & Co. Filed: 2025-05-15 AccNo: 0001821825-25-000037 Size: 5 KB

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

New Form SCHEDULE 13G/A - PMV Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049430 Size: 13 KB

New Form 5 - IGC Pharma, Inc. Filed: 2025-05-15 AccNo: 0001185185-25-000493 Size: 11 KB

New Form 4 - Allakos Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049427 Size: 19 KB

New Form 10-Q - IMMUNIC, INC. Filed: 2025-05-15 AccNo: 0001280776-25-000008 Size: 11 MB

New Form 8-K - MANNKIND CORP Filed: 2025-05-15 AccNo: 0001193125-25-120797 Size: 142 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form SCHEDULE 13G/A - Avid Bioservices, Inc. Filed: 2025-05-15 AccNo: 0001076809-25-000049 Size: 9 KB

New Form 10-Q - Sharps Technology Inc. Filed: 2025-05-15 AccNo: 0001641172-25-010894 Size: 15 MB

New Form 8-K - RenovoRx, Inc. Filed: 2025-05-15 AccNo: 0001641172-25-010895 Size: 349 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates

UTHR: Notification